MAPT and Alzheimer disease: Our results are consistent with these published data, showing that the blockage of Nogo/NgR pathway significantly attenuated amyloidogenic processing of APP and the activity of GSK3β in AD mice, which reduced Aβ deposition and phosphorylated levels of tau, respectively.